Cooley Advises Cell Therapy Biz On London Market Exit
By Irene Madongo ( April 15, 2025, 3:10 PM BST) -- MaxCyte Inc. said Tuesday that it plans to quit the junior Alternative Investment Market in London — but will continue to list on the Nasdaq in New York where a large chunk of the cell therapy engineer's shares are traded....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.